SpyBiotech featured in The Guardian Value of Vaccines supplement
New technology platform helps accelerate vaccine generation SpyBiotech has today been featured in The Guardian’s Value of Vaccines supplement, discussing the technological solutions we have developed to accelerate vaccine generation for COVID-19 variants and potentially a range of other diseases for which there are no approved treatments. “The COVID-19 vaccine uses SpyBiotech’s unique protein “superglue” […]
SpyBiotech featured in The Guardian Value of Vaccines supplement Read More »